Goldman Sachs have initiated coverage: • Buy • 12 month price target $1.90 https://drive.google.com/open?id=1l12RntXY5DLTx_kA0GYLGHFYHS0aRlVP
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game